Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Schwabe

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Biochemistry|August 7, 2007
Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3)Erika E Büllesbach, Christian Schwabe
Biochemistry|May 12, 2012
Replacement of disulfides by amide bonds in the relaxin-like factor (RLF/INSL3) reveals a role for the A11-B10 link in transmembrane signalingErika E Büllesbach, Christian Schwabe
Reproduction (Cambridge, England)|February 27, 2008
Cryptorchidism induced in normal rats by the relaxin-like factor inhibitorErika E Büllesbach, Fredric R Boockfor, George Fullbright, et al.
Oncology and Therapy|July 7, 2024
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind StudyChristian Schwabe, Chris Wynne, Dayaker Reddy Dyapa, et al.
Journal of Clinical Pharmacology|March 19, 2013
Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast CancerChris Wynne, Vernon Harvey, Christian Schwabe, et al.
Journal of Clinical Pharmacology|February 26, 2013
Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancerChris Wynne, Vernon Harvey, Christian Schwabe, et al.
British Journal of Clinical Pharmacology|June 27, 2018
A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin<sup>®</sup> (EU and US) in healthy male subjectsChris Wynne, Christian Schwabe, Sonica Sachdeva Batra, et al.
American Journal of Veterinary Research|January 3, 2008
Transmission of relaxin and estrogens to suckling canine pups via milk and possible association with hip joint laxityBernard G Steinetz, Alma J Williams, George Lust, et al.
Biopharmaceutics & Drug Disposition|April 22, 2018
Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasisMysore S Anil Kumar, Kim Papp, Ryo Tainaka, et al.
Molecular Endocrinology (Baltimore, Md.)|January 31, 2002
The overexpression of the insl3 in female mice causes descent of the ovariesIbrahim M Adham, Gerd Steding, Tarvo Thamm, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Biochemistry|August 7, 2007
Structure of the transmembrane signal initiation site of the relaxin-like factor (RLF/INSL3)Erika E Büllesbach, Christian Schwabe
Biochemistry|May 12, 2012
Replacement of disulfides by amide bonds in the relaxin-like factor (RLF/INSL3) reveals a role for the A11-B10 link in transmembrane signalingErika E Büllesbach, Christian Schwabe
Reproduction (Cambridge, England)|February 27, 2008
Cryptorchidism induced in normal rats by the relaxin-like factor inhibitorErika E Büllesbach, Fredric R Boockfor, George Fullbright, et al.
Oncology and Therapy|July 7, 2024
Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind StudyChristian Schwabe, Chris Wynne, Dayaker Reddy Dyapa, et al.
Journal of Clinical Pharmacology|March 19, 2013
Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast CancerChris Wynne, Vernon Harvey, Christian Schwabe, et al.
Journal of Clinical Pharmacology|February 26, 2013
Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancerChris Wynne, Vernon Harvey, Christian Schwabe, et al.
British Journal of Clinical Pharmacology|June 27, 2018
A comparative pharmacokinetic study of DRL_BZ, a candidate biosimilar of bevacizumab, with Avastin<sup>®</sup> (EU and US) in healthy male subjectsChris Wynne, Christian Schwabe, Sonica Sachdeva Batra, et al.
American Journal of Veterinary Research|January 3, 2008
Transmission of relaxin and estrogens to suckling canine pups via milk and possible association with hip joint laxityBernard G Steinetz, Alma J Williams, George Lust, et al.
Biopharmaceutics & Drug Disposition|April 22, 2018
Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasisMysore S Anil Kumar, Kim Papp, Ryo Tainaka, et al.
Molecular Endocrinology (Baltimore, Md.)|January 31, 2002
The overexpression of the insl3 in female mice causes descent of the ovariesIbrahim M Adham, Gerd Steding, Tarvo Thamm, et al.
Pageof 6